000 01634 a2200445 4500
005 20250517204007.0
264 0 _c20180919
008 201809s 0 0 eng d
022 _a1477-9234
024 7 _a10.1039/c7dt04232a
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPasha, Sheik Saleem
245 0 0 _aEvaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.
_h[electronic resource]
260 _bDalton transactions (Cambridge, England : 2003)
_cMar 2018
300 _a4613-4624 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aAptamers, Nucleotide
_xchemistry
650 0 4 _aCell Cycle Checkpoints
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDrug Carriers
_xchemical synthesis
650 0 4 _aFluorescent Dyes
_xchemistry
650 0 4 _aHumans
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aPlatinum
_xchemistry
650 0 4 _aPorosity
650 0 4 _aSilicon Dioxide
_xchemistry
650 0 4 _aTheranostic Nanomedicine
_xmethods
700 1 _aFageria, Leena
700 1 _aCliment, ClĂ udia
700 1 _aRath, Nigam P
700 1 _aAlemany, Pere
700 1 _aChowdhury, Rajdeep
700 1 _aRoy, Aniruddha
700 1 _aLaskar, Inamur Rahaman
773 0 _tDalton transactions (Cambridge, England : 2003)
_gvol. 47
_gno. 13
_gp. 4613-4624
856 4 0 _uhttps://doi.org/10.1039/c7dt04232a
_zAvailable from publisher's website
999 _c28158106
_d28158106